Drug Information

Drug General Information
Drug ID
D02OEI
Former ID
DNC012555
Drug Name
3-(2,3-Dimethyl-phenyl)-piperidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534764]
Formula
C13H19N
Canonical SMILES
CC1=CC=CC(=C1C)C2CCCNC2
InChI
1S/C13H19N/c1-10-5-3-7-13(11(10)2)12-6-4-8-14-9-12/h3,5,7,12,14H,4,6,8-9H2,1-2H3
InChIKey
TXQGNZXKUWJMKW-UHFFFAOYSA-N
PubChem Compound ID
10679213
Target and Pathway
Target(s) D(2) dopamine receptor Target Info Inhibitor [534764]
KEGG Pathway Rap1 signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Alcoholism
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
Reactome Dopamine receptors
G alpha (i) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic Neurons
References
Ref 534764J Med Chem. 1998 Dec 3;41(25):4933-8.N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies.
Ref 534764J Med Chem. 1998 Dec 3;41(25):4933-8.N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.